Lexeo Therapeutics, Inc.'s total assets for Q3 2024 were $173.87M, a decrease of -9.45% from the previous quarter. LXEO total liabilities were $34.54M for the fiscal quarter, a 27.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.